NAACCR Item #3889: Methylation of O6-Methylguanine-Methyltransferase
Padding Character' '
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired||Column #|
|3889||1||NAACCR||1742 - 1742|
NAACCR XML: Tumor.methylationOfO6MethylguanineMethyltransferase
O6-Methylguanine-Methyltransferase (MGMT) is an enzyme in cells that repairs DNA. Methylation of the MGMT gene reduces production of MGMT enzyme and the ability of tumor cells to repair damage caused by chemotherapy. Methylation of MGMT is a prognostic and predictive factor for high grade gliomas.
Methylation of O6-Methylguanine-Methyltransferase (MGMT) is a Registry Data Collection Variable in AJCC. It was previously collected as Brain, CS SSF #4.
|0||MGMT methylation absent/not present, unmethylated MGMT|
|1||MGMT methylation present, low level
|2||MGMT methylation present, high level
|3||MGMT Methylation present, level unspecified|
|6||Benign or borderline tumor|
|7||Test ordered, results not in chart|
|8||Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
|9||Not documented in patient record
Cannot be determined by the pathologist
MGMT not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.